Application 078083
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | TABLET;ORAL | 2.5MG;250MG | No | No |
| 002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | TABLET;ORAL | 2.5MG;500MG | No | No |
| 003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | TABLET;ORAL | 5MG;500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | ||
| A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | ||
| A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | GLIPIZIDE; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | AB | 2007-04-12 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | AB | 2007-04-12 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | AB | 2007-04-12 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | AB | 2007-04-12 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078083-001 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;250MG | TABLET / ORAL | 2007-04-12 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078083-002 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 2.5MG;500MG | TABLET / ORAL | 2007-04-12 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A078083-003 | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET / ORAL | 2007-04-12 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A078083-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A078083-003 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | A078083-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A078083-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A078083-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A078083-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 1b18b903-eb52-4d08-b4a5-f984957eb116 | 2026-06-27 | Warnings, Adverse reactions | Glipizide and Metformin Hydrochloride |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 03d9ce02-0559-494c-a53d-de9b9a64b606 | 2026-06-11 | Warnings, Adverse reactions | Glipizide and Metformin Hydrochloride |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 4a2d814b-93a1-4487-b789-dbafe9f0ffd3 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | Glipizide and Metformin Hydrochloride |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | AvKARE | 13be49d2-0ce9-a78a-e557-ded85ddc808f | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | Glipizide and Metformin Hydrochloride |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | Zydus Lifesciences Limited | bd2e1c06-424b-4222-b723-90ffdcc3983c | 2024-11-30 | Glipizide and Metformin Hydrochloride |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-3131 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3132 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3132 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3133 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-3133 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 70518-0116 | Glipizide and Metformin Hydrochloride | glipizide and metformin hydrochloride | REMEDYREPACK INC. | ANDA | Current |